Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 80353 refers to a laboratory test specifically designed to measure the presence of cocaine in various biological specimens, including meconium stool, urine, serum, or plasma. Cocaine is classified as a highly addictive substance that acts as a central nervous system stimulant and anesthetic, originating from the leaves of the coca plant. This substance functions as a triple reuptake inhibitor (TRI), meaning it influences the brain's neurotransmitter systems by affecting serotonin, norepinephrine, and dopamine receptors. Cocaine can be administered through various routes, including inhalation, injection, or topical absorption. For the purpose of this test, a blood sample is typically obtained through a procedure known as venipuncture, which is separately reportable. Urine samples can be collected either through random voiding or catheterization, while meconium stool is gathered from a diaper. The analysis of serum, plasma, meconium stool, and positive urine screens is conducted using advanced techniques such as quantitative gas chromatography-mass spectrometry and quantitative liquid chromatography-tandem mass spectrometry, ensuring accurate measurement of cocaine levels in the tested specimens.
© Copyright 2026 Coding Ahead. All rights reserved.
The laboratory test coded as CPT® 80353 is indicated for the detection and measurement of cocaine in various biological specimens. The following conditions or situations may warrant the performance of this test:
The procedure for conducting the cocaine test coded as CPT® 80353 involves several key steps to ensure accurate collection and analysis of the specimens. Each step is critical to the integrity of the test results.
After the completion of the cocaine testing procedure, the laboratory will analyze the collected specimens and generate a report detailing the findings. It is essential for healthcare providers to review the results in conjunction with clinical assessments and patient history. Depending on the outcomes, further actions may be warranted, such as additional testing, referrals for substance abuse treatment, or legal reporting in forensic cases. Patients may also be advised on the implications of the test results, particularly in the context of treatment for substance use disorders or legal matters. Proper documentation and communication of the results are crucial for ensuring appropriate follow-up care and interventions.
| Short Descr | DRUG SCREENING COCAINE | Medium Descr | DRUG SCREENING COCAINE | Long Descr | Cocaine | Status Code | Not Valid for Medicare Purposes | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Code Not Recognized by OPPS when submitted on Outpatient Hospital Part B Bill Type (12x/13x) | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T2D - Other tests - other | MUE | 1 |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2015-01-01 | Added | Added |
Get instant expert-level medical coding assistance.